Inflammatory Marker Predicts Mortality in Hemodialysis Patients
Author Information
Author(s): Tsai Yu-Che, Lee Chien-Te, Huang Tiao-Lai, Cheng Ben-Chung, Kuo Chien-Chun, Su Yih, Ng Hwee-Yeong, Yang Chih-Chau, Chuang Fong-Rong, Liao Shang-Chih
Primary Institution: Chang-Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University, College of Medicine
Hypothesis
Can biomarkers of inflammation, adipokines, and clinical features predict the outcomes of hemodialysis patients?
Conclusion
Chronic inflammation and low albumin levels are strongly related to mortality in long-term hemodialysis patients.
Supporting Evidence
- 41 out of 181 patients died during the 3-year follow-up period.
- Elevated serum levels of hsCRP and albumin were highly associated with death.
- Age, diabetes, albumin level, and hsCRP were independent factors predicting mortality.
Takeaway
This study found that patients on long-term dialysis who have high inflammation markers and low albumin levels are more likely to die.
Methodology
The study followed 181 hemodialysis patients for 36 months, analyzing demographic data, biomarkers, and clinical features to predict mortality.
Limitations
The study had a small sample size and a relatively short follow-up period.
Participant Demographics
The participants were 181 Taiwanese hemodialysis patients, with a mean age of 56.3 years, including 97 men.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website